| Bioactivity | Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-life, low toxicity. Clevudine is a non-competitive inhibitor that is not incorporated into the viral DNA but rather binds to the polymerase. Clevudine is active against cowpox virus respiratory infection in mice[1][2][3]. | ||||||||||||
| Invitro | Clevudine (L-FMAU) shows some activity against Epstein-Barr virus[2]. | ||||||||||||
| Name | Clevudine | ||||||||||||
| CAS | 163252-36-6 | ||||||||||||
| Formula | C10H13FN2O5 | ||||||||||||
| Molar Mass | 260.22 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Asselah T, et al. Clevudine: a promising therapy for the treatment of chronic hepatitis B. Expert Opin Investig Drugs. 2008;17(12):1963-1974. [2]. Yoo BC, et al. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology. 2007;46(4):1041-1048. [3]. Smee DF, et, al. Progress in the discovery of compounds inhibiting orthopoxviruses in animal models. Antivir Chem Chemother. 2008;19(3):115-24. |
Clevudine
CAS: 163252-36-6 F: C10H13FN2O5 W: 260.22
Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-li
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.